BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31671446)

  • 1. Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.
    Cooper LV; Ronveaux O; Fernandez K; Lingani C; Goumbi K; Ihekweazu C; Preziosi MP; Durupt A; Trotter CL
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S244-S252. PubMed ID: 31671446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
    Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.
    Nnadi C; Oladejo J; Yennan S; Ogunleye A; Agbai C; Bakare L; Abdulaziz M; Mohammed A; Stephens M; Sumaili K; Ronveaux O; Maguire H; Karch D; Dalhat M; Antonio M; Bita A; Okudo I; Nguku P; Novak R; Bolu O; Shuaib F; Ihekweazu C
    MMWR Morb Mortal Wkly Rep; 2017 Dec; 66(49):1352-1356. PubMed ID: 29240724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
    Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
    Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
    Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF
    BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysing spatio-temporal clustering of meningococcal meningitis outbreaks in Niger reveals opportunities for improved disease control.
    Paireau J; Girond F; Collard JM; Maïnassara HB; Jusot JF
    PLoS Negl Trop Dis; 2012; 6(3):e1577. PubMed ID: 22448297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger.
    Maïnassara HB; Oumarou GI; Issaka B; Sidiki A; Idi I; Pelat JM; Fontanet A; Mueller JE
    Trop Med Int Health; 2017 Feb; 22(2):196-204. PubMed ID: 27860062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time delays in the response to the Neisseria meningitidis serogroup C outbreak in Nigeria - 2017.
    Hassan A; Mustapha GU; Lawal BB; Na'uzo AM; Ismail R; Womi-Eteng Oboma E; Oyebanji O; Agenyi J; Thomas C; Balogun MS; Dalhat MM; Nguku P; Ihekweazu C
    PLoS One; 2018; 13(6):e0199257. PubMed ID: 29920549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neisseria meningitidis Serogroup W Meningitis Epidemic in Togo, 2016.
    Mounkoro D; Nikiema CS; Maman I; Sakandé S; Bozio CH; Tall H; Sadji AY; Njanpop-Lafourcade BM; Sibabe A; Landoh DE; Abodji EO; Kodjo A; Tamekloe TA; Essoh TA; Maba DW; Gessner BD; Moïsi JC
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S216-S224. PubMed ID: 31671438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?
    Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF
    Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.
    Maïnassara HB; Paireau J; Idi I; Pelat JP; Oukem-Boyer OO; Fontanet A; Mueller JE
    Emerg Infect Dis; 2015 Aug; 21(8):1322-9. PubMed ID: 26196461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
    Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
    Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
    Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S
    Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.
    Arifin SMN; Zimmer C; Trotter C; Colombini A; Sidikou F; LaForce FM; Cohen T; Yaesoubi R
    Med Decis Making; 2019 Jul; 39(5):553-567. PubMed ID: 31268405
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of cerebrospinal meningitis and impact of the 2015 meningococcal C vaccination in Kebbi, Northwest Nigeria.
    Ajibola O; Omoleke SA; Omisakin OA
    Vaccine; 2018 Mar; 36(11):1423-1428. PubMed ID: 29426659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.
    Ferrari MJ; Fermon F; Nackers F; Llosa A; Magone C; Grais RF
    Int Health; 2014 Dec; 6(4):282-90. PubMed ID: 25193978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningitis outbreaks and vaccination strategy.
    Varaine F; Caugant DA; Riou JY; Kondé MK; Soga G; Nshimirimana D; Muhirwa G; Ott D; Høiby EA; Fermon F; Moren A
    Trans R Soc Trop Med Hyg; 1997; 91(1):3-7. PubMed ID: 9093614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin for contacts of cases of meningococcal meningitis as an epidemic response: study protocol for a cluster-randomized trial.
    Coldiron ME; Alcoba G; Ciglenecki I; Hitchings M; Djibo A; Page AL; Langendorf C; Grais RF
    Trials; 2017 Jun; 18(1):294. PubMed ID: 28646924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.